Adynxx, Inc.
Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2M | $2.0M | $16.3M | $12.2M | $4.8M | $1.8M |
| Operating income | −$5.3M | −$4.8M | −$31.8M | −$29.5M | −$25.4M | −$20.1M |
| Net income | −$8.4M | −$25.7M | −$28.2M | −$26.0M | −$25.4M | −$22.0M |
| Total assets | $9.7M | $32.9M | $54.5M | $89.8M | $29.7M | $17.5M |
| Total liabilities | $1.4M | $17.3M | $22.4M | $37.3M | $7.2M | $3.5M |
| Equity | $8.3M | $15.7M | $32.1M | $52.4M | $22.5M | $14.0M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 5.0M | 35.1M | 27.7M | 16.8M | 12.5M | 263.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2018- Operating margin
- −239.0%
- Net margin
- −379.8%
- Return on equity
- −102.0%
- Return on assets
- −87.0%
- Return on capital (ROCE)
- −63.8%
- Liabilities / assets
- 14.7%
- Debt / equity
- 0.17×
- Book value / share
- $1.66
- Revenue growth (YoY)
- 9.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2018- Altman Z″ (distress)
- -45.59distress
- Accruals / assets
- 13.4%high accruals
- Beneish M-Score
- -2.89normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- High accruals — earnings-quality risk
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2013
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2008
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2007
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2006
- NT 10-Kmissed a reporting deadline ↗Mar 30, 2004
- NT 10-K/Amissed a reporting deadline ↗Mar 27, 2003
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Abel Stan EDirector | May 3, 2019 | Grant | 54,117 | — |
| Weber EckardDirector | May 3, 2019 | Grant | 85,254 | — |
| Podlesak DennisDirector | May 3, 2019 | Grant | 85,254 | — |
| Mamet JulienOfficer — CHIEF SCIENTIFIC OFFICER | May 3, 2019 | Grant | 240,454 | — |
| Orr RickOfficer — CHIEF EXECUTIVE OFFICER | May 3, 2019 | Grant | 142,090 | — |
| Barton BradfordOfficer — Chief Operating Officer | Sep 21, 2017 | Tax withholding | 67,536 | $0.42 |
| Posner Brian MOfficer — Chief Financial Officer | Sep 21, 2017 | Tax withholding | 70,833 | $0.42 |
| Pionati PellegrinoOfficer — See Remarks | Sep 21, 2017 | Tax withholding | 69,978 | $0.42 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Unregistered equity saleDec 17, 2019
- Results of operations · Prior financials not reliable (restatement)Nov 14, 2019
- Regulation FD disclosureOct 2, 2019
- Results of operationsAug 14, 2019
- Delisting / listing-standard notice · Unregistered equity saleAug 1, 2019
- Director / officer changeJul 22, 2019
- Director / officer change · Regulation FD disclosureJun 26, 2019
- Terminated a material agreementJun 17, 2019
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BMar 20, 2020
- S-8 POSMar 20, 2020
- S-8 POSMar 20, 2020
- S-8 POSMar 20, 2020
- S-8 POSMar 20, 2020
- RWMar 20, 2020
- 8-KFORM 8-KDec 17, 2019
- S-1/ANov 14, 2019
- 10-QFORM 10-QNov 14, 2019
- 8-KFORM 8-KNov 14, 2019
- 10-Q/AFORM 10-Q/ANov 14, 2019
- S-1/ANov 8, 2019
- S-1/AOct 11, 2019
- 8-KFORM 8-KOct 2, 2019
- S-1/AAug 22, 2019
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.